These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23902712)

  • 1. Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease.
    Klawitter J; Zafar I; Klawitter J; Pennington AT; Klepacki J; Gitomer BY; Schrier RW; Christians U; Edelstein CL
    BMC Nephrol; 2013 Jul; 14():165. PubMed ID: 23902712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
    Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
    Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD).
    Zafar I; Belibi FA; He Z; Edelstein CL
    Nephrol Dial Transplant; 2009 Aug; 24(8):2349-53. PubMed ID: 19321761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
    Pey R; Bach J; Schieren G; Gretz N; Hafner M
    In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease.
    Zhang T; Wang L; Xiong X; Mao Z; Wang L; Mei C
    Biol Res; 2009; 42(4):437-44. PubMed ID: 20140299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Sphingosine-1-Phosphate Modulator Ameliorates Polycystic Kidney Disease in Han:SPRD Rats.
    Li X; Wu M; Chen L; Lu J; Li G; Fu L; Qi N; Lin Y; Sun Z; Wang X; Zhang H; Liu J; Jiang H; Li L; Mei CL; Luo C
    Am J Nephrol; 2020; 51(1):1-10. PubMed ID: 31694015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
    Aukema HM; Housini I
    Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
    Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
    Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease.
    Wu M; Wahl PR; Le Hir M; Wackerle-Men Y; Wuthrich RP; Serra AL
    Kidney Blood Press Res; 2007; 30(4):253-9. PubMed ID: 17596700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saskatoon berry supplementation prevents cardiac remodeling without improving renal disease in an animal model of reno-cardiac syndrome.
    Raj P; Louis XL; Yu L; Siow YL; Suh M; Aukema HM; Netticadan T
    J Food Biochem; 2021 Oct; 45(10):e13893. PubMed ID: 34459008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study.
    Ogbron MR; Sareen S; Prychitko J; Buist R; Peeling J
    Am J Physiol; 1997 Jan; 272(1 Pt 2):F63-9. PubMed ID: 9039050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
    Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
    Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Fitzpatrick-Wong S; Aukema HM
    Kidney Int; 2003 Oct; 64(4):1214-21. PubMed ID: 12969139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
    Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
    Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
    Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease.
    Rodriguez D; Kapoor S; Edenhofer I; Segerer S; Riwanto M; Kipar A; Yang M; Mei C; Wüthrich RP
    Kidney Blood Press Res; 2015; 40(6):638-47. PubMed ID: 26698317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal endothelin system in polycystic kidney disease.
    Hocher B; Zart R; Schwarz A; Vogt V; Braun C; Thöne-Reineke C; Braun N; Neumayer HH; Koppenhagen K; Bauer C; Rohmeiss P
    J Am Soc Nephrol; 1998 Jul; 9(7):1169-77. PubMed ID: 9644626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.